SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.
Saved in:
| Title: | SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study. |
|---|---|
| Authors: | Latva-Rasku, Aino1,2 (AUTHOR) aino.e.latva-rasku@utu.fi, Rebelos, Eleni1 (AUTHOR), Tuisku, Jouni1 (AUTHOR), Aarnio, Richard1 (AUTHOR), Bhowmik, Achol1 (AUTHOR), Keskinen, Helmi1 (AUTHOR), Laurila, Sanna1,3 (AUTHOR), Lahesmaa-Hatting, Minna1 (AUTHOR), Pekkarinen, Laura1,2 (AUTHOR), Isackson, Henrik4,5 (AUTHOR), Kirjavainen, Anna K.6 (AUTHOR), Koffert, Jukka1 (AUTHOR), Heurling, Kerstin7 (AUTHOR), Nummenmaa, Lauri1,8 (AUTHOR), Ferrannini, Ele9 (AUTHOR), Oldgren, Jonas4,10 (AUTHOR), Oscarsson, Jan11 (AUTHOR), Nuutila, Pirjo1,2 (AUTHOR) |
| Source: | Diabetes Care. Sep2024, Vol. 47 Issue 9, p1630-1637. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01495992 |
|---|---|
| DOI: | 10.2337/dc24-0470 |
